Zentalis Pharmaceuticals (Series C)

Funding Details
Awarder
Inbox
Date Award
December 09, 2019
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$85,000,000

Company Info
Founders
Anthony Sun
Company Description
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Market
Oncology
Location
New York, NY, USA
Coinvestors
Eventide Asset Management, Farallon Capital Management, Matrix Capital Management, Perceptive Advisors, Redmile Group, Surveyor Capital, Viking Global Investors

Links